It is classified as channelopathy, indicating a gene mutation that translates to specific ion channels in the cardiac myocytes, namely ryanodine receptor-2 (RyR2) and calsequestrin-2 (CASQ2) channels [1]. Here, CASQ2 is linked to channelopathy.